HANNAH GLASSTETTER: Open Payments
NPI 1164069910 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 42 payments from 20 companies in 2025. Trend: 2023 $1,307 · 2024 $1,294 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 7 | $136 |
| Lilly USA, LLC | 7 | $123 |
| Dexcom, Inc. | 3 | $92 |
| Novo Nordisk Inc | 4 | $71 |
| Insulet Corporation | 1 | $58 |
| Xeris Pharmaceuticals, Inc. | 3 | $54 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| CeQur Corporation | 1 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| TOLMAR, INC. | 2 | $29 |
Products named: iLet Bionic Pancreas, Dexcom G6 Transmitter, MOUNJARO, JARDIANCE, Omnipod, CRENESSITY, CeQur Simplicity, GVOKE HYPOPEN.
Industry payments across OH — which companies pay providers there.
